# Uxin Ltd: Form 20-F for the period ended Mar 31, 2020

- Company: [Uxin Ltd](/companies/uxin.md) (CIK 1729173)
- Form: 20-F
- Filed: 2020-07-24
- Accepted by EDGAR: Jul 24, 2020, 16:08 ET
- Period: 2020-03-31
- Accession: 0001104659-20-086426
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729173/000110465920086426/uxin-20200331x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729173/000110465920086426/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $14.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $15.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | −$969.0k | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $4.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | −$308.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $4.1m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | $46.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$350.8m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | −$58.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $43.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2020-01-01 to 2020-03-31 | $989.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-03-31 | $48.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $316.2m | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $373.9m | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $434.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $705.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-03-31 | −$331.1m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729173/000110465920086426/uxin-20200331x20f.htm

Filed Jul 24, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-086426. Last ingested by Listed: Nov 13, 2026, 15:00 ET. No prices; not investment advice.
